NVUS - Novus Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 543.27M
Enterprise Value 329.8M
Trailing P/E N/A
Forward P/E 1-3.13
PEG Ratio (5 yr expected) 10.05
Price/Sales (ttm)N/A
Price/Book (mrq)1.68
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-3.28

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-51.62%
Return on Equity (ttm)-156.61%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-10.78M
Diluted EPS (ttm)-2.3040
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.23M
Total Cash Per Share (mrq)1.83
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)13.19
Book Value Per Share (mrq)2.74

Cash Flow Statement

Operating Cash Flow (ttm)-14.94M
Levered Free Cash Flow (ttm)-5.83M

Trading Information

Stock Price History

Beta -0.60
52-Week Change 3-16.49%
S&P500 52-Week Change 310.49%
52 Week High 36.6000
52 Week Low 33.1200
50-Day Moving Average 34.9913
200-Day Moving Average 34.2107

Share Statistics

Avg Vol (3 month) 363.03k
Avg Vol (10 day) 314.68k
Shares Outstanding 59.41M
Float 3.92M
% Held by Insiders 123.98%
% Held by Institutions 153.55%
Shares Short 346.08k
Short Ratio 33.06
Short % of Float 31.79%
Shares Short (prior month) 368.61k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/9
Last Split Date 3May 11, 2017